GC
RPTP

Globeflex Capital’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Globeflex Capital’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-212,739
Closed -$1.14M – 608
2016
Q2 		$1.14M Sell
212,739
-25,500
-11% -$131K 0.31% 112
2016
Q1 		$1.1M Buy
238,239
+28,452
+14% +$114K 0.29% 115
2015
Q4 		$1.09M Buy
209,787
+113,016
+117% +$656K 0.29% 123
2015
Q3 		$585K Sell
96,771
-13,000
-12% -$159K 0.13% 268
2015
Q2 		$1.73M Buy
+109,771
New +$1.33M 0.32% 80

Other funds holding RPTP

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Globeflex Capital's RPTP Position: Q3 2016 in Review

Globeflex Capital sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 212,739 shares — an estimated $1.14M sold.

Globeflex Capital first reported a position in RPTP in Q2 2015 and held it in 5 quarters. The position peaked at $1.73M in Q2 2015. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • Globeflex Capital reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Globeflex Capital sold 212,739 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $1.14M.
  • Globeflex Capital first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2015 and held it in 5 quarters.
  • Globeflex Capital's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.73M in Q2 2015.
  • 111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on Globeflex Capital's 13F filing for Q3 2016, filed 9 Nov 2016.